Quick Answer
SINOVAC BIOTECH LTD reported Total Assets of $13.66 billion for fiscal year 2023.
SINOVAC BIOTECH LTD Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2023 | $13.66B | -3.2% |
| 2022 | $14.11B | -15.7% |
| 2021 | $16.75B | +780.9% |
| 2020 | $1.90B | +320.4% |
| 2019 | $452.30M | +22.3% |
| 2018 | $369.78M | +23.6% |
| 2017 | $299.22M | +41.6% |
| 2016 | $211.35M | +4.2% |
| 2015 | $202.93M | -14.9% |
| 2014 | $238.53M | -0.9% |
| 2013 | $240.69M | +15.3% |
| 2012 | $208.76M | -3.3% |
| 2011 | $215.91M | +0.7% |
| 2010 | $214.36M | — |
- SINOVAC BIOTECH LTD showed a decrease of -3.2% in Total Assets compared to the prior fiscal year.
- Over the 2010–2023 period, SINOVAC BIOTECH LTD’s total assets has grown by 6271.6% (from $214.36 million to $13.66 billion).
- The most recent figure is from SINOVAC BIOTECH LTD’s fiscal year 2023 report (Form 20-F), filed with the SEC on April 29, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: